- Article
Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era
- Ioannis Ntanasis-Stathopoulos,
- Charalampos Filippatos,
- Maria Gavriatopoulou,
- Panagiotis Malandrakis,
- Evangelos Eleutherakis-Papaiakovou,
- Vassiliki Spiliopoulou,
- Rodanthi-Eleni Syrigou,
- Foteini Theodorakakou,
- Despina Fotiou and
- Evangelos Terpos
- + 4 authors
Background: tixagevimab/cilgavimab, distributed under the name “Evusheld”, was the first available pre-exposure prophylaxis for COVID-19 other than vaccination. It received an EUA from the FDA after sufficient trial data showed efficacy i...

